Mosanna Therapeutics raised an $80M Series A round co-led by Pivotal bioVenture Partners and EQT, with Forbion, Broadview Ventures, and Norwest Ventures.
01 June 2025
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal